Literature DB >> 27856472

Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.

Beenu Thakral1, Joseph D Khoury1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27856472     DOI: 10.1182/blood-2016-08-735795

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.

Authors:  Jonathon H Gralewski; Ginell R Post; Frits van Rhee; Youzhong Yuan
Journal:  Diagn Pathol       Date:  2018-02-20       Impact factor: 2.644

2.  KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.

Authors:  Sarah M Choi; Aleodor A Andea; Min Wang; Amir Behdad; Lina Shao; Yanming Zhang; Xinyan Lu; David Dittmann; Juan Castro; Yi-Hua Chen; Juehua Gao
Journal:  Diagn Pathol       Date:  2018-10-15       Impact factor: 2.644

3.  The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.

Authors:  Caoimhe Egan; Justin Lack; Shannon Skarshaug; Thu Anh Pham; Zied Abdullaev; Liqiang Xi; Svetlana Pack; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld
Journal:  Mod Pathol       Date:  2020-09-14       Impact factor: 8.209

Review 4.  Sarcoma as Second Cancer in a Childhood Cancer Survivor: Case Report, Large Population Analysis and Literature Review.

Authors:  Thinh H Nguyen; Monish Ram Makena; Siddhartha Yavvari; Maninder Kaur; Teresia Pham; Eduardo Urias; Narendra Panapitiya; Mohamad M Al-Rahawan
Journal:  Medicina (Kaunas)       Date:  2020-05-07       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.